Product Information

BRIMONIDINE TARTRATE 0.1% DROP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $6.0954 per ML under NDC 62332074915. Its NADAC has been published 135 times since Apr 17, 2024.

FDA first approved this application on Aug 1, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE TARTRATE 0.1% DROP

Brimonidine Tartrate
$6.0954per ML

Strength

1 mg/mL

NDC

62332074915

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

BRIMONIDINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA216909

FDA Approved

8/1/2023

TE Code

AB

On Market Since

8/1/2023

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for BRIMONIDINE TARTRATE 0.1% DROP has been published 135 times since Apr 17, 2024, and over the history we have for it it has declined 76.1%. The table below summarizes its recorded NADAC range and movement.

Current price$6.0954 per ML
All-time high$25.4636 (May 15, 2024)
All-time low$6.0954 (Oct 21, 2026)
52-week high$14.1665
52-week low$6.0954
Median price$13.6535
Average price$14.2350
Largest weekly change-15.4% (Jul 22, 2026)
Weeks tracked135
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

-7.0%

3M

-20.9%

6M

-40.2%

1Y

-57.2%

3Y

N/A

5Y

N/A

All

-76.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRIMONIDINE TARTRATE 0.1% DROP?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE TARTRATE 0.1% DROP, manufactured by Alembic Pharmaceuticals Inc., is $6.0954 per ML (NDC 62332074915), effective Nov 11, 2026.

How has the price of BRIMONIDINE TARTRATE 0.1% DROP changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has declined 76.1%. It has been tracked across 135 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE TARTRATE 0.1% DROP?

Since Apr 17, 2024, the NADAC for BRIMONIDINE TARTRATE 0.1% DROP has ranged from a low of $6.0954 (Oct 21, 2026) to a high of $25.4636 (May 15, 2024), with a median of $13.6535 per ML.

Are there cheaper alternatives to BRIMONIDINE TARTRATE 0.1% DROP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BRIMONIDINE TARTRATE 0.1% DROP in a comparable dosage form, but none are currently priced below it.

Who manufactures BRIMONIDINE TARTRATE 0.1% DROP?

BRIMONIDINE TARTRATE 0.1% DROP (NDC 62332074915) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.